ACE2 and Parkinsonism‑related bone metabolic alterations: signaling pathways and hub gene analysis
Preclinical findings indicate that Ace2 deficiency is associated with concurrent pathological abnormalities in the brain and transient bone metabolic disturbance under short-term MPTP treatment in growing young male mice, consistent with a potential bone-brain axis pathological phenotype.